Cell Biotech Co (XKRX:049960) Accounts Payable & Accrued Expense : ₩7,107 Mil (As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is Cell Biotech Co Accounts Payable & Accrued Expense?

Cell Biotech Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (₩2,668 Mil) to Dec. 2024 (₩3,815 Mil) and increased from Dec. 2024 (₩3,815 Mil) to Mar. 2025 (₩7,107 Mil).

Cell Biotech Co's annual accounts payable & accrued expense declined from Dec. 2022 (₩5,344 Mil) to Dec. 2023 (₩2,417 Mil) but then increased from Dec. 2023 (₩2,417 Mil) to Dec. 2024 (₩3,815 Mil).

Cell Biotech Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cell Biotech Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell Biotech Co Accounts Payable & Accrued Expense Chart

Cell Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2,729.63

3,527.30

5,344.36

2,417.40

3,815.44

Cell Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5,827.60	3,242.31	2,667.81	3,815.44	7,107.46

Cell Biotech Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cell Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cell Biotech Co Ltd (XKRX:049960) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

134 Gaegok-ri, Wolgot-myeon, Gimpo-si, Gyeonggi-Do, KOR, 415-872

Website

http://www.cellbiotech.com

Cell Biotech Co Ltd is a specialized biotech company. It is engaged in the fermentation and coating technology development as well as manufacturing probiotics and lactic acid bacteria. The key product consists Probiotic DUOLAC, Nutra DUOLAC, LACTOClear, and LAB2PRO. The company distributes its products within domestic market and to overseas markets.

Cell Biotech Co Headlines

No Headlines